Navigation Links
International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
Date:3/9/2010

COLUMBIA, S.C., March 9 /PRNewswire/ -- Conformity markings allow Rhythmlink International products to be marketed throughout Europe, launching Rhythmlink to a new level within the neurodiagnostic and health care industry.

As of January 28, 2010, Rhythmlink International received ISO 13485:2003 certification, in combination with official CE markings, following MDD 93/42/ECC Directives. Rhythmlink's quality management system was audited in accordance with ISO 13485:2003 and is recognized by the Canadian Medical Devices Conformity Assessment Scheme [CMDCAS] and the Standards Council of Canada [SCC] accredited notified body, TUV Rheinland.

Effective immediately, Rhythmlink may sell and market product within the European Union [EU] and partnering nations. "Our ISO 13485:2003 certification is key to the growth of the company. This certification demonstrates to the markets in the European Union that Rhythmlink will provide products backed by a quality management system that reduces risk to patients," said Martin Barry, Rhythmlink International's regulatory affairs specialist.

As an electrode manufacturing company, within the medical devices industry, Rhythmlink International is bound by strict FDA regulations and regulatory requirements. Rhythmlink's quality management system has demonstrated the ability to provide medical devices and services that consistently achieve customer and regulatory requirements, thus receiving ISO 13485:2003 certification and ISO 13485:2003 + AC:2007 CE Markings.

Under European Directives and supported by European standards, Rhythmlink and its products are in full compliance with essential health and safety requirements. The CE Marking is Rhythmlink's declaration that all products meet the essential requirements of the European directives.

For more information about Rhythmlink's certifications, products and services, visit Rhythmlink.com.

About Rhythmlink International, LLC

Rhythmlink International, LLC designs, manufactures and distributes neurodiagnostic accessories and provides custom OEM and manufacturing solutions to its customers.  Based in Columbia, S.C., Rhythmlink was established in 2002 and is owned and operated by CEO Shawn Regan and COO Michael O'Leary.  Rhythmlink's advancements and improvements in the areas of technology, business development and corporate branding have been recognized by entities such as the Columbia Information Technology Council, Inc. Magazine and the International Academy of the Visual Arts.  For more information about Rhythmlink International, its products or services, visit Rhythmlink.com.

SOURCE Rhythmlink International, LLC

Back to top

RELATED LINKS
http://www.rhythmlink.com

'/>"/>

SOURCE Rhythmlink International, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Concentric Medical and the Merci Retrieval System(R) Highlighted at the 2010 International Stroke Conference
2. Max Neeman International and AMEDON Collaborate to Increase EDC Performance
3. International Merchant Advisors Reaches Agreement in Principal to Acquire First Medical Marijuana Clinic Operations
4. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
5. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
6. PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
7. Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
8. Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International
9. International Merchant Advisors, Inc. Signs LOI to Invest in Pharmaceutical Chain
10. Max Neeman International Expands Specialized Surgical Team for Clinical Trials
11. Bacterin International Completes $3 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... 2016 Hutchison China MediTech ... on the highly lucrative global oncology and immunology ... potential first-in-class or best-in-class tyrosine kinase inhibitor (TKI) ... strategic partners. HCM,s profitable Chinese healthcare business continues ... expect progress of the mid-to-late-stage pipeline during 2016-17 ...
(Date:5/27/2016)... , May 27, 2016 Amarantus ... focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, ... will be presenting at two upcoming investor conferences: ... 730 Third Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand ...
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... An educational ... by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It also ... advocates, associations and industry leaders such as Bioness. , As patients feel ...
(Date:5/27/2016)... ... 2016 , ... Aimed at nurses and employees in the health care world, ... in the nursing and health care industry. It also provides insight to the developing ... , As the nursing industry is coming out of one of the biggest ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to ... Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of ... grilling is their favorite way to cook a hot dog, far outpacing other cooking ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... (IP) to its specialty academic programs. , Answering to the increasing demand for ... programs in health law, and environmental and land use law. ,  , “The ...
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
Breaking Medicine News(10 mins):